Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Broadcom
AVGO
|
$2.06B |
| 2 |
Nasdaq
NDAQ
|
$1.76B |
| 3 |
Wells Fargo
WFC
|
$1.1B |
| 4 |
Gilead Sciences
GILD
|
$978M |
| 5 |
Edwards Lifesciences
EW
|
$964M |
Top Sells
| 1 |
EOG Resources
EOG
|
$1.82B |
| 2 |
Apple
AAPL
|
$1.75B |
| 3 |
HCA Healthcare
HCA
|
$1.51B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$1.48B |
| 5 |
PNC Financial Services
PNC
|
$1.29B |
Sector Composition
| 1 | Technology | 23.24% |
| 2 | Healthcare | 19.6% |
| 3 | Financials | 13.95% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Cabaletta Bio
CABA
$155M
| $741K | ﹤0.01% |
157,051
-1,758
| -1% | -$8.3K |
|
1652
Kura Oncology
KURA
$713M
| $729K | ﹤0.01% |
37,302
-7,547
| -17% | -$147K |
|
1653
Viatris
VTRS
$12.2B
| $718K | ﹤0.01% |
61,874
-15,626
| -20% | -$181K |
|
1654
Elastic
ESTC
$9.21B
| $701K | ﹤0.01% |
9,134
+5,305
| +139% | +$407K |
|
1655
Alto Neuroscience
ANRO
$99.4M
| $694K | ﹤0.01% |
+60,636
| New | +$694K |
|
1656
Recursion Pharmaceuticals
RXRX
$2.01B
| $692K | ﹤0.01% |
+105,018
| New | +$692K |
|
1657
Organogenesis Holdings
ORGO
$634M
| $691K | ﹤0.01% |
241,648
+17,842
| +8% | +$51K |
|
1658
Larimar Therapeutics
LRMR
$337M
| $689K | ﹤0.01% |
105,246
+63,563
| +152% | +$416K |
|
1659
Amneal Pharmaceuticals
AMRX
$3.02B
| $687K | ﹤0.01% |
+82,596
| New | +$687K |
|
1660
Roku
ROKU
$14B
| $681K | ﹤0.01% |
9,125
-462
| -5% | -$34.5K |
|
1661
Southern California Bancorp
BCAL
$556M
| $680K | ﹤0.01% |
45,963
| – | – |
|
1662
Apollo Global Management
APO
$75.3B
| $677K | ﹤0.01% |
5,423
-211,631
| -98% | -$26.4M |
|
1663
Foghorn Therapeutics
FHTX
$326M
| $672K | ﹤0.01% |
72,216
+28,427
| +65% | +$265K |
|
1664
Janux Therapeutics
JANX
$1.44B
| $659K | ﹤0.01% |
14,498
-29,436
| -67% | -$1.34M |
|
1665
American Financial Group
AFG
$11.6B
| $658K | ﹤0.01% |
4,888
-3,435
| -41% | -$462K |
|
1666
Ameriprise Financial
AMP
$46.1B
| $642K | ﹤0.01% |
1,366
-532
| -28% | -$250K |
|
1667
Alector
ALEC
$305M
| $639K | ﹤0.01% |
+137,152
| New | +$639K |
|
1668
Marathon Digital Holdings
MARA
$5.63B
| $636K | ﹤0.01% |
39,231
+4,334
| +12% | +$70.3K |
|
|
AVDL
1669
Avadel Pharmaceuticals
AVDL
$1.53B
| $633K | ﹤0.01% |
+48,236
| New | +$633K |
|
|
JOYY
1670
JOYY Inc. American Depositary Shares
JOYY
$3.21B
| $632K | ﹤0.01% |
17,441
-73,923
| -81% | -$2.68M |
|
1671
TScan Therapeutics
TCRX
$108M
| $629K | ﹤0.01% |
126,345
+35,404
| +39% | +$176K |
|
1672
Fulcrum Therapeutics
FULC
$414M
| $629K | ﹤0.01% |
176,161
-6,568
| -4% | -$23.4K |
|
1673
Harmony Biosciences
HRMY
$2.07B
| $626K | ﹤0.01% |
15,642
-10,485
| -40% | -$419K |
|
1674
MeiraGTx Holdings
MGTX
$619M
| $624K | ﹤0.01% |
149,747
-19,312
| -11% | -$80.5K |
|
|
GAP
1675
The Gap, Inc.
GAP
$8.83B
| $616K | ﹤0.01% |
+27,932
| New | +$616K |
|